A procedure for preparing a Pharmaceutical composition comprising a compound to provide a First combination of proteasome inhibitor peptide, Cyclodextrins and Water, and then put her in contact with an acid to form a Second Combination； and Pharmaceutical composition (divisio The nal Application no. 2622 - 12).

• 收藏
• 分享

专利权人:

ONYX THERAPEUTICS INC

发明人:

LEWIS, EVAN,SHWONEK, PETER,DALZIEL, SEAN,JUMAA, MOUHANNAD

申请号：

CL2013001680

公开号：

CL2013001680A1

申请日:

2013.06.11

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

A procedure for preparing a Pharmaceutical composition comprising a compound to provide a First combination of proteasome inhibitor peptide, Cyclodextrins and Water, and then put her in contact with an acid to form a Second Combination； and Pharmaceutical composition (divisio The nal Application no. 2622 - 12).PROCEDIMIENTO PARA FORMULAR UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE UNA ETAPA DE COMBINACIÓN DE CICLODEXTRINAS CON CARFILZOMIB, INHIBIDOR DEL PROTEASOMA PEPTÍDICO, Y AGUA, Y UNA SEGUNDA ETAPA DE PONER EN CONTACTO ESTA COMBINACIÓN CON UN ÁCIDO PARA FORMAR UNA SEGUNDA COMBINACIÓN； COMPOSICIÓN FARMACÉUTICA (DIV. SOL. 2622-2012).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/